AETHLON MEDICAL, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
AETHLON MEDICAL, INC. (AEMD) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $50.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $50.00K, a 30.98% decline year-over-year.
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $72.44K, a 19.48% decline year-over-year.
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $72.44K, a 36.17% decline year-over-year.
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $72.44K, a 48.01% decline year-over-year.
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $278.55K, a 32.92% decline from fiscal 2025.
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $415.23K, a 65.95% decline from fiscal 2024.
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.22M, a 15.92% increase from fiscal 2023.
- AETHLON MEDICAL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.05M, a 40.14% increase from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $278.55K 10-K · filed 2026-06-10 | |||
| 2025-12-31 | $72.44K 10-Q · filed 2026-02-12 | $144.88K derived: sum of 2 quarters · filed 2026-02-12 | $217.33K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-09-30 | $72.44K 10-Q · filed 2026-02-12 | $144.88K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $72.44K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $415.23K 10-K · filed 2026-06-10 | |||
| 2024-12-31 | $89.97K 10-Q · filed 2026-02-12 | $203.46K derived: sum of 2 quarters · filed 2026-02-12 | $342.79K derived: sum of 3 quarters · filed 2026-02-12 | |
| 2024-09-30 | $113.49K 10-Q · filed 2026-02-12 | $252.82K derived: sum of 2 quarters · filed 2026-02-12 | ||
| 2024-06-30 | $139.33K 10-Q · filed 2026-02-12 | |||
| 2024-03-31 | $1.22M 10-K · filed 2025-06-26 | |||
| 2023-12-31 | $572.96K 10-Q · filed 2025-02-12 | $830.14K derived: sum of 2 quarters · filed 2025-02-12 | $1.08M derived: sum of 3 quarters · filed 2025-02-12 | |
| 2023-09-30 | $257.18K 10-Q · filed 2025-02-12 | $507.30K derived: sum of 2 quarters · filed 2025-02-12 | ||
| 2023-06-30 | $250.11K 10-Q · filed 2025-02-12 | |||
| 2023-03-31 | $1.05M 10-K · filed 2024-06-27 | |||
| 2022-12-31 | $262.61K 10-Q · filed 2024-02-14 | $576.15K derived: sum of 2 quarters · filed 2024-02-14 | $791.59K derived: sum of 3 quarters · filed 2024-02-14 | |
| 2022-09-30 | $313.54K 10-Q · filed 2024-02-14 | $528.98K derived: sum of 2 quarters · filed 2024-02-14 | ||
| 2022-06-30 | $215.44K 10-Q · filed 2024-02-14 | |||
| 2022-03-31 | $750.62K 10-K · filed 2023-06-28 | |||
| 2021-12-31 | $201.02K 10-Q · filed 2023-02-13 | $402.08K derived: sum of 2 quarters · filed 2023-02-13 | $522.24K derived: sum of 3 quarters · filed 2023-02-13 | |
| 2021-09-30 | $201.06K 10-Q · filed 2023-02-13 | $321.22K derived: sum of 2 quarters · filed 2023-02-13 | ||
| 2021-06-30 | $120.15K 10-Q · filed 2023-02-13 | |||
| 2021-03-31 | $779.42K 10-K · filed 2022-06-28 | |||
| 2020-12-31 | $377.96K 10-Q · filed 2022-02-14 | $545.00K derived: sum of 2 quarters · filed 2022-02-14 | $629.21K derived: sum of 3 quarters · filed 2022-02-14 | |
| 2020-09-30 | $167.04K 10-Q · filed 2022-02-14 | $251.25K derived: sum of 2 quarters · filed 2022-02-14 | ||
| 2020-06-30 | $84.21K 10-Q · filed 2022-02-14 | |||
| 2020-03-31 | $844.00K 10-K · filed 2021-06-24 | |||
| 2019-12-31 | $102.58K 10-Q · filed 2021-02-10 | $429.11K derived: sum of 2 quarters · filed 2021-02-10 | $755.65K derived: sum of 3 quarters · filed 2021-02-10 | |
| 2019-09-30 | $326.54K 10-Q · filed 2021-02-10 | $653.07K derived: sum of 2 quarters · filed 2021-02-10 | ||
| 2019-06-30 | $326.54K 10-Q · filed 2021-02-10 | |||
| 2019-03-31 | $1.32M 10-K · filed 2020-06-25 | |||
| 2018-12-31 | $344.85K 10-Q · filed 2020-02-10 | $681.35K derived: sum of 2 quarters · filed 2020-02-10 | $944.51K derived: sum of 3 quarters · filed 2020-02-10 | |
| 2018-09-30 | $336.50K 10-Q · filed 2020-02-10 | $599.66K derived: sum of 2 quarters · filed 2020-02-10 | ||
| 2018-06-30 | $263.16K 10-Q · filed 2020-02-10 | |||
| 2018-03-31 | $1.26M 10-K · filed 2019-07-01 | |||
| 2017-03-31 | $2.19M 10-K · filed 2018-06-08 | |||
| 2016-03-31 | $202.84K 10-K · filed 2017-06-28 | |||
| 2015-03-31 | $418.48K 10-K · filed 2016-06-29 | |||
| 2014-03-31 | $607.95K 10-K · filed 2015-07-13 | |||
| 2013-03-31 | $765.27K 10-K · filed 2014-07-15 | |||
| 2012-03-31 | $758.96K 10-K · filed 2013-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |